RSRanjay Shaw

Ranjay Shaw

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ranjay Shaw has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Design and Synthesis of Novel 1,2,3‐Triazole Conjugates Featuring Hydroxamic Acid and Sulfonamide Moieties: Exploring Dual Pharmacophores for Enhanced Biological Activity

    by Dineshkumar Pagar, Ranjay Shaw, Hemant Suryavanshi, Dhanji Rajani, Sudhakar Patil

    A new series of N ‐hydroxy‐1‐(4‐(aryl sulfonamido)phenyl)‐1 H ‐1,2,3‐triazole‐4‐carboxamide derivatives ( 8a ‐ j ) were synthesized through a concise multistep route integrating three key pharmacophores: the 1,2,3‐triazole core, an aryl sulfonamide moiety, and an N ‐hydroxycarboxamide group. Biological evaluation demonstrated promising antimicrobial potential for several derivatives. Compounds 8f , 8g , and 8i exhibited notable antibacterial activity against both Gram‐positive and Gram‐negative bacteria, whereas most analogues showed weak antifungal activity. In the antimalarial assay, compound 8d emerged as the most potent derivative (IC 50 = 0.84 μg/mL), while compounds 8b , 8e , 8g , and 8h also displayed appreciable activity. Antitubercular evaluation identified compounds 8g and 8i as the most active derivatives against Mycobacterium tuberculosis H37Rv, with MIC values of 62.5 and 50 μg/mL, respectively. The molecular docking study against DNA gyrase (PDB ID: 7FVT) and lanosterol 14α‐demethylase (PDB ID: 5V5Z) as relevant antibacterial and antifungal targets, respectively, showed a similar trend of activity. Computational studies, including molecular docking, MM/GBSA, molecular dynamics simulations, and ADME prediction, supported the structural and pharmacokinetic characteristics of the synthesized compounds, with selected derivatives exhibiting favorable interactions with the c‐KIT kinase active site and generally acceptable drug‐like properties. Overall, these triazole–sulfonamide–N‐hydroxycarboxamide hybrids represent promising lead molecules for further structural optimization and biological investigation.

  • Open Access

    Synthesis of photoactive compounds from 2 H -pyran-2-ones and their photophysical properties

    by Ranjay Shaw, Rohit Yadav Kosliya, Ismail Althagafi, Pooja, Ramendra Pratap

    This review explored 2 H -pyran-2-ones and their derivatives as valuable building blocks for assembling different photoactive compounds. Their photophysical properties are presented.

  • Open Access

    Arylsulfonyl Phenols as Potential gp120-Targeted HIV-1 Entry Inhibitors: Design, Synthesis, and Anti-HIV-1 Evaluation

    by Ranjay Shaw, Shyam Bharat Yadav, Neha Taneja

    The development of antiretroviral agents that disrupt the early interaction between Human immunodeficiency virus type-1 (HIV-1) and host cells offers an attractive alternative to therapies targeting viral enzymes. In this study, we evaluate arylsulfonyl phenols, a diarylsulfone subclass, as small-molecule CD4 antagonists that inhibit the envelope glycoprotein 120 (gp120) using combined in silico and in vitro approaches. Designed to occupy the hydrophobic Phe43 cavity and adjacent β20/21 region of gp120, these compounds show enhanced drug-likeness, balanced polarity, high membrane permeability, and improved predicted oral bioavailability relative to the attachment inhibitor fostemsavir. Molecular docking and MM GBSA analyses identified 5o, 5m, 5e, 5a, 5j, 4b, and 4d as high affinity compounds with favourable predicted gp120 binding scores of −7.52 to −8.26 kcal/mol and ΔGbind values of −49.71 to −56.14 kcal/mol, exceeding those of fostemsavir and the reference CD4 antagonist NBD-11021. Fifty-nanosecond molecular dynamics simulations further supported stable gp120-ligand complexes for 5o, 5m, 5a, and 5j. In vitro antiviral assays in C8166 cells demonstrated potent activity, with EC50 values of 0.0162–0.2130 μM and high therapeutic indices (TI); notably, 5a (EC50 = 0.0162 μM, TI = 162,839.51) and 5m (EC50 = 0.0238 μM, TI = 124,159.66) showed antiviral potencies approaching zidovudine (AZT). In this study, we investigated arylsulfonyl phenols, a diarylsulfone subclass, as potential small-molecule inhibitors of HIV-1 entry targeting the gp120–CD4 interaction using integrated computational and in-vitro approaches and highlight 5a and 5m as candidates for further optimization as next-generation attachment blockers.

  • A green and cascade synthesis of functionalized 2-aminothiophenes from ketene dithioacetals

    by Mohit Chahal, Ranjay Shaw, Pratik Yadav, Vishnu Bhardwaj, Ismail Althagafi, Ramendra Pratap

    One-pot multicomponent reactions were developed for the synthesis of tetrasubstituted aminothiophenes in water. The column chromatography-free approach was found to be useful for the synthesis of pharmaceutically active analogues.

  • Open Access

    The stereo-divergent functionalization of alkynes: a comprehensive review

    by Ranjay Shaw, Ashmita Singh, Ismail Althagafi, Ramendra Pratap, Dharmendra Kumar Yadav

    Alkynes are central in crafting pharmaceuticals, agrochemicals, and materials owing to their reactivity and linear geometry. This review unveils cutting-edge advancements in the stereo-divergent functionalization of alkynes, transforming them into invaluable tools for synthesizing stereochemically defined alkenes and alkanes. The review highlights ground-breaking methodologies that achieve exceptional E- and Z-selectivity using innovative catalysts like cobalt, nickel, and palladium through hydrogenation, hydroboration, and hydrosilylation. Recent breakthroughs such as dual-catalytic systems and energy transfer catalysis enable unprecedented stereocontrol. Sustainable strategies including water as a hydrogen source and recyclable catalysts align with green chemistry principles, paving the way for eco-friendly synthesis. This synthesis of cutting-edge techniques and their applications inspire new avenues in synthetic chemistry, offering transformative tools for creating complex molecular architectures with precision and sustainability.


  • Open Access

    A green approach towards the on-water synthesis of multifunctional 3-amino/hydroxy thieno[3,2-c]pyrans

    by Satya Narayan Sahu, Ranjay Shaw, Saroj Yadav, Ismail Althagafi, Manmohan Krishna Upadhyay, Ramendra Pratap

    An efficient, one-pot, and green synthesis of 3-amino/hydroxy thieno[3,2-c]pyrans was acheived from 2-oxo-2H-pyran-3-carbonitriles/carboxylates in water.


  • Structure-based pharmacophore modelling for ErbB4-kinase inhibition: a systematic computational approach for small molecule drug discovery for breast cancer

    by R. Shaw, R. Pratap

    ErbB2 kinase is a key target in approximately 20% of breast cancer cases; however, ErbB2-positive cells may shift their dependence to ErbB4 upon developing resistance to ErbB2 inhibitors. Targeting ErbB4 presents a viable strategy to address this challenge. This study employs a comprehensive approach combining structure-based pharmacophore modelling, molecular docking, and MM-GBSA calculations to identify novel ErbB4 kinase inhibitors. Critical pharmacophoric features were extracted from the crystal structures of ErbB4-lapatinib, followed by virtual screening of the Chembl database to discover potential small molecule candidates. Furthermore, the ADMET profiles of 11 shortlisted candidates were assessed to verify their pharmacokinetic and toxicity properties, identifying Chembl310724, Chembl521284, and Chembl4168686 as promising inhibitors of ErbB4 kinase activity with the binding free energy (ΔGbind) values of -99.84, -89.42 and -86.06 kcal/mol, respectively. This integrated methodology not only enhances our understanding of ErbB4 inhibition but also sets a foundation for the rational design of targeted therapies addressing breast cancer with ErbB4 dependency.

  • Thiamine (Vitamin B1) Promoted Organic Transformations: A Recent Updates

    by Ranjay Shaw, Prasoon Prakash

    Due to the growing significance of sustainable and environmentally friendly organic transformations, there has been increasing interest in utilizing vitamins as catalysts owing to their green nature, biocompatibility, and ease of preparation. Among these, Vitamin B1, also known as thiamine stands out for its nonflammable, water‐soluble, inexpensive, and non‐toxic characteristics. This review summarized recent developments on the catalytic application of Vitamin B1 in organic transformations, particularly in facilitating C−C and C−X (N, O, S) bond formations, thus demonstrating its efficacy in synthesizing complex molecules. Vitamin B1 exhibits versatility in these reactions, functioning as both an organocatalyst as well as a co‐catalyst or ligand with other metal catalysts. The review also delves into the application of thiamine diphosphate‐dependent enzymes as catalysts in organic reactions, drawing inspiration from natural enzymatic processes. Additionally, the mechanistic intricacies of thiamine‐catalyzed reactions and the roles of co‐catalysts or additives are thoroughly examined, providing insights into reaction pathways and facilitating informed catalyst design strategies.


  • Open Access

    Recent advancements in the synthesis of fused thienopyridines and their therapeutic applications

    by Ranjay Shaw, Ritu Tewari, Monika Yadav, Ekta Pandey, Khyati Tripathi, Jyoti Rani, Ismail Althagafi, Ramendra Pratap


  • Influence of steric hindrance on the 1,4- versus 1,6-Michael addition: synthesis of furans and pentasubstituted benzenes

    by Shally Rana, Ranjay Shaw, Ramendra Pratap

    We described the influence of steric hindrance on the 1,4- versus 1,6-Michael addition reaction on 2-(3,3-bis(methylthio)-1-arylallylidene)malononitriles.